Draft concept paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus

  • Email
  • Help

Document details

Download document Draft concept paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus
Reference number EMA/CHMP/BWP/78086/2014
Status draft: consultation closed
First published 2014-05-02
Last updated 2014-05-02

Summary

Viral safety of plasma-derived medicinal products needs to be kept under review as viruses are identified that can be present in the plasma starting material. Initiating action with a workshop will provide an effective means of bringing together and discussing the currently available information on this topic. This will then allow further actions to be identified.